These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21821359)

  • 1. Development of an egg hatch assay for the diagnosis of triclabendazole resistance in Fasciola hepatica: proof of concept.
    Fairweather I; McShane DD; Shaw L; Ellison SE; O'Hagan NT; York EA; Trudgett A; Brennan GP
    Vet Parasitol; 2012 Feb; 183(3-4):249-59. PubMed ID: 21821359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
    Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
    Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep.
    Flanagan A; Edgar HW; Gordon A; Hanna RE; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Mar; 176(2-3):170-6. PubMed ID: 21112153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening anthelmintic resistance to triclabendazole in Fasciola hepatica isolated from sheep by means of an egg hatch assay.
    Robles-Pérez D; Martínez-Pérez JM; Rojo-Vázquez FA; Martínez-Valladares M
    BMC Vet Res; 2015 Aug; 11():226. PubMed ID: 26314580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of two isolates of Fasciola hepatica to treatment with triclabendazole in vivo and in vitro.
    Walker SM; McKinstry B; Boray JC; Brennan GP; Trudgett A; Hoey EM; Fletcher H; Fairweather I
    Parasitol Res; 2004 Dec; 94(6):427-38. PubMed ID: 15517388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
    Flanagan AM; Edgar HW; Forster F; Gordon A; Hanna RE; McCoy M; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Feb; 176(1):34-42. PubMed ID: 21093156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasciola hepatica: comparative effects of host resistance and parasite intra-specific interactions on size and reproductive histology in flukes from rats infected with isolates differing in triclabendazole sensitivity.
    Hanna RE; Gordon AW; Moffett D; Edgar HW; Oliver LF; McConnell S; Shaw L; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Jun; 178(3-4):251-63. PubMed ID: 21333449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.
    Meaney M; Savage J; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2013 Sep; 140(10):1287-303. PubMed ID: 23756576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitology; 2009 Feb; 136(2):183-92. PubMed ID: 19079818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fasciola hepatica: histological demonstration of apoptosis in the reproductive organs of flukes of triclabendazole-sensitive and triclabendazole-resistant isolates, and in field-derived flukes from triclabendazole-treated hosts, using in situ hybridisation to visualise endonuclease-generated DNA strand breaks.
    Hanna RE; Forster FI; Brennan GP; Fairweather I
    Vet Parasitol; 2013 Jan; 191(3-4):240-51. PubMed ID: 23062689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasciola hepatica: histological changes in the reproductive structures of triclabendazole (TCBZ)-sensitive and TCBZ-resistant flukes after treatment in vivo with TCBZ and the related benzimidazole derivative, Compound Alpha.
    Hanna RE; Edgar HW; McConnell S; Toner E; McConville M; Brennan GP; Devine C; Flanagan A; Halferty L; Meaney M; Shaw L; Moffett D; McCoy M; Fairweather I
    Vet Parasitol; 2010 Mar; 168(3-4):240-54. PubMed ID: 20053501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts.
    Hanna RE; Edgar H; Moffett D; McConnell S; Fairweather I; Brennan GP; Trudgett A; Hoey EM; Cromie L; Taylor SM; Daniel R
    Vet Parasitol; 2008 Nov; 157(3-4):222-34. PubMed ID: 18774647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the P-glycoprotein inhibitor, R(+)-verapamil on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Vet Parasitol; 2013 Jul; 195(1-2):72-86. PubMed ID: 23597772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.
    Ortiz P; Scarcella S; Cerna C; Rosales C; Cabrera M; Guzmán M; Lamenza P; Solana H
    Vet Parasitol; 2013 Jul; 195(1-2):118-21. PubMed ID: 23352107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2010 May; 106(6):1351-63. PubMed ID: 20336319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperonyl butoxide enhances triclabendazole action against triclabendazole-resistant Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitology; 2011 Feb; 138(2):224-36. PubMed ID: 20946692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for high genetic diversity of NAD1 and COX1 mitochondrial haplotypes among triclabendazole resistant and susceptible populations and field isolates of Fasciola hepatica (liver fluke) in Australia.
    Elliott T; Muller A; Brockwell Y; Murphy N; Grillo V; Toet HM; Anderson G; Sangster N; Spithill TW
    Vet Parasitol; 2014 Feb; 200(1-2):90-6. PubMed ID: 24360656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triclabendazole resistance in Fasciola hepatica: First report in sheep from the Santa Cruz province, Argentinian Patagonia.
    Larroza M; Aguilar M; Soler P; Mora J; Roa M; Cabrera R; Martinez Stanziola JP; Ceballos L; Alvarez LI
    Vet Parasitol Reg Stud Reports; 2023 Oct; 45():100927. PubMed ID: 37783530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.